All Shareholder Proposals

Click on the magnifying glass to view more info.

Filter results:

Showing 251–300 of 340 filings

Meeting Date ▼ Company Form Short Summary ESG View
2026-05-04 AFLAC INC DEF 14A Adopt a policy requiring the Chairman and CEO roles to be separate and that the Board Chair be an independent director. S G
2026-05-04 WEST PHARMACEUTICAL SERVICES INC DEF 14A Adopt a policy requiring the Board Chair and CEO roles be separated and that the Board Chair be an independent director. G
2026-05-02 BERKSHIRE HATHAWAY INC DEF 14A Publish a report disclosing the Board’s oversight framework for workforce and human-capital management across its operating subsidiaries. S G
2026-05-02 CINCINNATI FINANCIAL CORP DEF 14A Give shareholders holding 10% of outstanding common stock (or the lowest percentage permitted by state law) the power to call a special shareholder meeting and require the bylaws be published on the company website. G
2026-05-01 ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ DEF 14A Conduct an evaluation and issue a report within one year on how Zions’ policies, public statements, and partnerships may be misaligned with its customer base and the resulting legal, regulatory, and reputational risks. S G
2026-05-01 RYDER SYSTEM INC DEF 14A Require the Board to adopt a policy that the Board Chair be an independent director separate from the CEO. G
2026-05-01 AMN HEALTHCARE SERVICES INC DEF 14A Require the Board to adopt a policy separating the roles of Chair and CEO and to ensure the Chair is an independent director. G
2026-05-01 CHURCH & DWIGHT CO INC /DE/ DEF 14A Authorize shareholders to take corporate action by written consent if they hold at least the number of votes required to approve the action at a meeting. G
2026-04-30 BOSTON SCIENTIFIC CORP DEF 14A Grant shareholders holding 10% of outstanding common stock the right to call a special shareholder meeting. G
2026-04-30 GILEAD SCIENCES, INC. DEF 14A Adopt an enduring policy requiring the roles of Board Chair and CEO be held by separate persons and that the Chair be an independent director. G
2026-04-30 GILEAD SCIENCES, INC. DEF 14A Commission a report assessing how extending patent exclusivities could delay biosimilars and novel therapeutics and thereby hinder patient access. S G
2026-04-30 CORNING INC /NY DEF 14A Adopt a policy requiring the Board Chair to be an independent director who has not previously served as a company executive. G
2026-04-30 GLOBAL PAYMENTS INC DEF 14A Permit shareholders to act by written consent with the minimum votes required to authorize an action at a fully attended meeting, and allow shareholders to initiate such consents. G
2026-04-30 CROWN HOLDINGS, INC. DEF 14A Amend governing documents to permit shareholders holding the minimum number of votes required to act by written consent to initiate and approve actions without requiring a meeting. G
2026-04-30 GILEAD SCIENCES, INC. DEF 14A Commission and publish a report evaluating risks to shareholder value, reputation and legal compliance from incorporating ESG and DEI metrics into executive compensation. S G
2026-04-30 RB GLOBAL INC. DEF 14A Adopt a policy to hold all shareholder meetings in a hybrid format allowing both in-person and virtual participation. G
2026-04-30 NRG ENERGY, INC. DEF 14A Give shareholders the ability to call a special shareholder meeting if holders of a combined 10% of outstanding common stock (or the lowest percentage permitted by law) request one. G
2026-04-30 LITHIA MOTORS INC DEF 14A Require the Board to appoint an independent Chair separate from the CEO. G
2026-04-30 PAPA JOHNS INTERNATIONAL INC DEF 14A Allow shareholders holding 15% of voting shares to call a special meeting by amending the company’s governing documents. G
2026-04-30 Avery Dennison Corp DEF 14A Adopt a policy requiring separate individuals for the Chairman and CEO roles and require the Chairman be an independent director. G
2026-04-29 PILGRIMS PRIDE CORP DEF 14A Disclose policies, recipients, and amounts of corporate political contributions and election-related expenditures in a periodic report. G
2026-04-29 COCA COLA CO DEF 14A Publish a report describing the Company’s processes and policies for assessing and managing health, reputational and financial risks from chemicals and additives in its products. S G
2026-04-29 HUNTINGTON INGALLS INDUSTRIES, INC. DEF 14A Disclose an annual report on the Company’s political spending, including policies, procedures, and detailed direct and indirect contributions and recipients. G
2026-04-29 COCA COLA CO DEF 14A Require the Corporate Governance and Sustainability Committee to evaluate sustainability initiatives using NPV and ROI and report findings annually. G
2026-04-29 BORGWARNER INC DEF 14A Allow stockholders holding the minimum number of votes necessary to authorize an action at a meeting to take action by written consent without ownership-length restrictions. G
2026-04-29 Huntsman CORP DEF 14A Adopt a policy to separate the roles of Chair and CEO and require the Board Chair to be an independent director. G
2026-04-29 GOLDMAN SACHS GROUP INC DEF 14A Lower the shareholder threshold to call a special meeting from 25% to 10%. G
2026-04-29 AES CORP DEF 14A Allow shareholders owning 10% of outstanding common stock to call a special shareholder meeting. G
2026-04-28 REVVITY, INC. DEF 14A Require the five named executive officers to retain 25% of net after-tax shares acquired through equity compensation until retirement and prohibit hedging of those shares. G
2026-04-28 BRINKS CO DEF 14A Publish a report disclosing employee retention rates by demographic categories (e.g., veteran status, age, gender, race, disability), prepared at reasonable cost and omitting proprietary information. S G
2026-04-28 Constellation Energy Corp DEF 14A Assess and report whether Constellation’s DEI initiatives are supported by net-present-value and return-on-investment analyses, including opportunity costs and litigation/reputational risks. S G
2026-04-28 WELLS FARGO & COMPANY/MN DEF 14A Produce a report evaluating climate‑related litigation risks tied to the firm’s financing of high‑carbon activities, excluding confidential information. E G
2026-04-28 WELLS FARGO & COMPANY/MN DEF 14A Disclose annually an Energy Supply Ratio showing the firm’s finance for low‑carbon energy supply versus fossil‑fuel energy supply, with methodology and scope. E G
2026-04-28 WELLS FARGO & COMPANY/MN DEF 14A Amend governing documents to replace any supermajority voting requirements with majority-of-votes-cast standards and remove remaining supermajority provisions. G
2026-04-28 WELLS FARGO & COMPANY/MN DEF 14A Separate the Chair and CEO roles and require the Board Chair to be an independent director whenever practicable. G
2026-04-28 AUTONATION, INC. DEF 14A Disclose an annual greenhouse gas report showing current GHG emissions and any timebound reduction targets, and update it annually. E S G
2026-04-28 AUTONATION, INC. DEF 14A Adopt an enduring policy separating the roles of Chairman and CEO and require an independent Board Chairman. G
2026-04-28 CF Industries Holdings, Inc. DEF 14A Require shareholder approval for any named executive officer severance or termination payments exceeding 2.99Ă— base salary plus target short-term bonus. G
2026-04-28 TRUIST FINANCIAL CORP DEF 14A Report on alignment risks: Request the Board to evaluate and issue a report on how Truist’s policies, public statements, and corporate partnerships may be misaligned with its customer base and expose the company to legal, regulatory, and reputational risk. S G
2026-04-28 INTERNATIONAL BUSINESS MACHINES CORP DEF 14A Permit shareholders to act by written consent when holders controlling the minimum votes needed to approve an action (as if at a meeting of all stockholders) request it. G
2026-04-28 INTERNATIONAL BUSINESS MACHINES CORP DEF 14A Require outside directors to personally own a meaningful amount of IBM common stock (not deferred Promised Fee Shares) within a set timeframe. G
2026-04-24 STANLEY BLACK & DECKER, INC. DEF 14A Require the Board to adopt a permanent policy separating the roles of Chair and CEO and appoint an independent Chair. G
2026-04-24 ARCBEST CORP /DE/ DEF 14A Adopt measurable GHG emissions reduction targets and report annually on progress. E S G
2026-04-23 IQVIA HOLDINGS INC. DEF 14A Adopt an enduring policy to separate the roles of Chairman and CEO and require the Board Chair to be an independent director. G
2026-04-23 SELECT MEDICAL HOLDINGS CORP DEF 14A Allow shareholders holding a combined 10% of outstanding common stock to call a special shareholder meeting (including online meetings) without a shareholder holding-period requirement. G
2026-04-23 FASTENAL CO DEF 14A Disclose Fastenal's Consolidated EEO-1 Report annually on its website and in its proxy statement. S G
2026-04-23 CITIZENS FINANCIAL GROUP INC/RI DEF 14A Adopt a 'majority of votes cast' standard in the company's charter and bylaws, replacing any voting thresholds greater than a simple majority. G
2026-04-23 JOHNSON & JOHNSON DEF 14A Require the Board to adopt a policy (and amend bylaws as needed) that the Board Chair must be an independent director, with limited waivers. G
2026-04-23 HCA Healthcare, Inc. DEF 14A Permit shareholders to act by written consent, allowing the minimum number of shareholders required to authorize corporate actions to take action without a meeting. G
2026-04-23 EDISON INTERNATIONAL DEF 14A Require named executive officers to retain 25% of net after-tax shares acquired through equity compensation until retirement. G